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Introduction. To evaluate the role of hyperthermic isolated limb perfusion (HILP) in arterial thrombosis following melanoma-
soft tissue sarcoma chemotherapy. Report. Here is presented one case of iliac-common femoral artery subacute thrombosis and
a review of the appropriate literature performed using a MEDLINE search. Acute/subacute arterial occlusion is one of the most
fearedvascularcomplicationsofHILP,locatednearlyalwaysintheexternaliliac-femoralarteryaxis,beingthosevesselscannulated
for perfusion. Conclusions. The small number of reported cases indicates either the rarity of this complication or unawareness of
its existence. The true incidence of this complication is probably underreported.
1. Article
We here present a case of arterial thrombosis following
hyperthermic isolated limb perfusion (HILP), a surgical
procedure involving an open surgical cannulation of iliac or
femoral vessels that is commonly employed in the manage-
ment of some forms of malignant tumors as extremity sar-
coma or melanoma. In particular, HILP is indicated in those
patients with melanoma who did not have systemic disease
and who may therefore survive for months or years with
bulky and unsightly limb metastases that might cause pain
and discomfort if HILP is not undertaken [1]. During HILP,
high temperature chemotherapeutic agents are recirculated
within an extremity and reach tissue concentrations that
are 20–30 times higher than during systemic chemotherapy,
thereby avoiding any systemic side-eﬀects. Little attention,
however,hasbeenpaidtovascularcomplications,whichmay
jeopardize the success of this procedure [2].
2.CaseDescription
A 48-year-old woman was admitted to our hospital with
diagnosis of subacute thrombosis of the right external iliac
and common femoral artery, following HILP for recurrence
of right limb melanoma. HILP was performed 3 weeks prior:
common right femoral artery and vein were isolated with
open technique, heparin was given, and then the vessels were
cannulated and connected to a perfusion circuit providing
membrane oxygenation and a heat exchanger (perfusate
temperature 38.5–40◦C). Melphalan was given in a dose of
10mg/L of tissue volume and human recombinant TNF-α in
a dose of 2mg. A duplex ultrasound of the right iliac and
femoral vessels performed preoperatively to assess vessel size
documented good quality vessels and, of note, the absence
of peripheral vascular disease (a contraindication to HILP).
Several days after, another duplex scan was obtained, as
postprocedural routine, to document regular vessels patency
but, unexpectedly, it showed a postocclusive demodulated
duplex signal, with the femoro-popliteal-tibial axis reper-
fused by collateral circulation, being the patient asymp-
tomatic for claudicatio or limb pain and with a slight clinical
evidence of limb ischemia. We carried out a multidetector
64-slice CT angiography (collimation 64mm × 0.625mm;
tube current 300mA, tube voltage 120Kv) after injection of
two intravenous bolus of contrast dye (Iomeron 350mg/mL;2 International Journal of Vascular Medicine
Table 1: Incidence of vascular complications after HILP in the literature.
Reference Arterial thrombosis Thrombosis site HILP drugs
Rochlin (1965) 2/200 (1%) Femoral artery Melphalan
Fontaine (1974) 1/56 (1.8%) External iliac artery Melphalan
Bulman (1980) 4/75 (5.3%) Femoral artery Melphalan
Krementz (1994) 6/703 (0.9%) Femoral artery Drug combinations
Hohenberger (1994) 3/342 (0.9%) External iliac artery Drug Combinations
Klicks (1998) 10/466 (2.1%) External iliac artery TNF-α + Melphalan
Rossi (2004) 1/20 (5%) Femoral artery TNF-α + Melphalan
Grunhagen (2005) 1/217 (0.5%) Mesenteric artery TNF-α + Melphalan
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Figure 1: Axial view of right external iliac artery thrombosis. No
contrast-enhancement is visible.
ﬁrst bolus 60mL volume, 4mL/s ﬂow; second bolus 40mL
volume, 2mL/sec ﬂow). The evaluation was completed by
volume rendering and multiplanar reconstructions (MPR).
As shown in Figure 1, the external iliac artery was com-
pletely occluded by a thrombus and reperfusion ﬂow was
appreciated in the distal common femoral artery and in
profunda femoris by collateral circulation. The patient
underwent surgical intervention consisting in iliac artery-
femoral artery bypass with a Dacron vascular graft 8mm in
caliper. Postprocedural hospital stay was uneventful, and she
was discharged home on day 11.
3. Discussion
Despite promising data, HILP is only used in a few centres
worldwide for the principal reason that although the proce-
dureissimpleinconcept,itissurgicallyandtechnicallycom-
plex, and demanding in practice [3]. Acute/subacute arterial
occlusion is one of the most feared vascular complications
of HILP, located nearly always in the external iliac-femoral
artery axis (Table 1). Usually patients who experience such
condition are females. Regarding the cause of thrombosis
and the role of the drugs used, there is evidence that
TNF-α targets the tumor vascular endothelial cells, increases
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Figure 2: Postprocessing 3D reconstruction of the iliac stenosis and
the collateral circulation reperfusing mainly the profunda femoris
from the omolateral internal iliac artery.
tumor vascular leakiness, decreases tumor blood ﬂow, and
selectively disrupts tumor endothelial junctions by changing
localization of VE-Cadherin. For this reason, endothelial
damage cannot be excluded as a possible cause that may
amplify surgical trauma, leading to subacute thrombosis.
In the absence of peripheral vascular disease, subacute
external iliac-femoral artery occlusion rarely produces limb-
threatening symptoms, especially in patients who often are
forcedly bed-bound. In such a localized obstruction, the
potential for collateral circulation is great. The major visceral
routes for collateral pathways are the lumbar and internal
iliac to profunda femoris (Figure 2). Multidetector CT
angiography with MPR is now considered the noninvasive
tool of choice for imaging the vascular system and is
appropriate for preprocedural planning and postprocedural
control, in particular for lower extremity inﬂow and runoﬀ
studies [4]. In case of HILP-related vascular complications,
its unvaluable aid helps surgeons to plan and to oﬀer
the best treatment option. In conclusion, major vascular
complications following HILP may develop in the early
postoperative phase; close post-HILP monitoring of the
peripheral circulation in perfused limbs is necessary in earlyInternational Journal of Vascular Medicine 3
detectionofthesecomplications,asearlysurgicalreinterven-
tion may lead to a good outcome with no sequelae.
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